Modulation of midazolam 1-hydroxylation activity in vitro by neurotransmitters and precursors

European Journal of Clinical Pharmacology

Volumn 56, Issue 2, 2000, Pages 145-151

  Martinez C ^a   Gervasini, G ^a   Agundez J A G ^a   Carrillo, J A ^a   Ramos, S I ^a   Garcia Gamito F J ^b   Gallardo, L ^a   Benitez J ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b Hospital de Mérida   (Spain)

Author keywords

CYP3A; Indoleamines; Metabolism

Indexed keywords

ADRENALIN; CYTOCHROME P450 3A; CYTOCHROME P450 ISOENZYME; MIDAZOLAM; NEUROTRANSMITTER; SEROTONIN;

ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; HUMAN; HUMAN CELL; HYDROXYLATION; IN VITRO STUDY; KINETICS; LIVER MICROSOME; NEUROTRANSMISSION; PRIORITY JOURNAL;

EID: 0034129703     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050733     Document Type: Article

References (45)

1. Agúndez JAG, Gallardo L, Martínez C, Gervasini G, Bonítez J (1998) Modulation of CYP1A2 enzyme activity by indoleamines. Inhibition by serotonin and tryptamine. Pharmacogenetics 8: 251-258
2. Back DJ, Stevenson P, Tjia JF (1989) Comparative effects of two antimycotic agents, ketoconazole and terfenadine on the metabolism of tolbutamide, ethinyloestradiol, clyclosporin and ethoxycoumarin by human liver microsomes in vitro. Br J Clin Pharmacol 28: 166-170
3. Bargetzi MJ, Aoyama T, Gonzalez FJ, Meyer UA (1989) Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4. Clin Pharmacol Ther 46: 521-527
4. Beck O, Borg S, Edman G, Fyro B, Oxenstierna G, Sedvall G (1984a) 5-hydroxytryptophol in human cerebrospinal fluid: conjugation, concentration gradient, relationship to 5-hydroxyindoleacetic acid, and influence of hereditary factors. J Neurochem 43: 58-61
5. Beck O, Borg S, Jonsson G, Lundman A, Valverius P (1984b) Measurement of 5-hydroxytryptophol and 5-hydroxyindoleacetic acid in human and rat brain and plasma. J Neural Transm 59: 57-67
6. Bhamre S, Anandatheeraavarada HK, Shankar SK, Boyd MR, Ravindranath V (1993) Purification of multiple forms of cytochrome P450 from a human brain and reconstitution of catalytic activities. Arch Biochem Biophys 310: 251-255
7. Carrillo JA, Ramos SI, Agúndez JAG, Martínez C, Benítez J (1998) Analysis of midazolam and metabolites in plasma by high performance liquid chromatography. A probe of CYP3A. Ther Drug Monit 20: 319-324
8. Combalbert J, Fabre I, Fabre G, et al. (1989) Metabolism of cyclosporin A; IV: purification and identification of the rifampin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily. Drug Metab Dispos 17: 197-207
9. Dalsgaard-Nielsen J, le Fèvre Honorè P, Zeeberg I (1982) Changes in platelet function and blood serotonin level in migraine patients during treatment with femoxetine. Acta Neurol Scand 66: 191-198
10. De Waziers I, Cugnene PH, Yang CS, Leroux JP, Beaune PH (1990) Cytochrome P450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extra-hepatic tissues. J Pharmacol Exp Ther 253: 387-394
11. Ensinger H, Lindner KH, Dirks B, Kilian J, Grunert A, Ahnefeld FW (1992) Adrenaline: relationship between infusion rate, plasma concentration, metabolic and haemodynamic effects in volunteers. Eur J Anaesthesiol 9: 435-446
12. Farin FM, Omiecinski CJ (1993) Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue. J Toxicol Environ Health 40: 317-335
13. García-Agúndez JA, Luengo A, Bonítez J (1990) Aminopyrine N-demethylase activity in human liver microsomes. Clin Pharmacol Ther 45: 490-495
14. Gascon MP, Dayer P (1991) In vitro forecasting of drugs which may interfere with the biotransformation of midazolam. Eur J Clin Pharmacol 41: 573-578
15. Gorski JC, Hall SD, Jones DR, VandenBranden M, Wrighton SA (1994) Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) sub-family. Biochem Pharmacol 47: 1643-1653
16. Greenblatt DJ, von Moltke LL, Schmider J, Harmatz JS, Shader RI (1996) Inhibition of human cytochrome P450-3A isoforms by fluoxetine and norfluoxetine: in vitro and in vivo studies. J Clin Pharmacol 36: 792-798
17. Guengerich FP, Martin MV, Beaune PH, Kremers P, Wolff T, Waxman DJ (1986) Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J Biol Chem 261: 5051-5060
18. Huang JL, Cheng FC, Chen YT, Ting CT (1996) Effect of quinapril therapy on blood pressure and serotonin change in patients with mild to moderate hypertension. Chung Hua I Hsueh Tsa Chih 58: 329-334
19. Janardan SK, Lown KS, Schmiedlin-Ren P, Thummel KE, Watkins PB (1996) Selective expression of CYP3A5 and not CYP3A4 in human blood. Pharmacogenetics 6: 379-385
20. Jayyosi Z, Cooper KO, Thomas PE (1992) Brain cytochrome P450 and testosterone metabolism by rat brain subcellular fractions: presence of cytochrome P450 3A immunoreactive protein in rat brain mitochondria. Arch Biochem Biophys 298: 265-270
21. Jounaïdi Y, Hyrailles V, Gervot L, Mauril P (1996) Detection of a CYP3A5 allelic variant: a candidate for the polymorphic expression of the protein? Biochem Biophys Res Commun 221: 466-470
22. Kerr BM, Thummel KE, Wurden CJ, Klein SM, Kroetz DL, Gonzalez FJ, Levy RM (1994) Human liver carbamazepine metabolism. Role of CYP3A and CYP2C8 in 10,11-epoxide formation. Biochem Pharmacol 47: 1969-1979
23. Kirches E, Scherlach C, von Bossanyi P, Schneider T, Szibor R, Kutz E, Warich-Kirches M, Dietzmann K (1999) MGMT-and P450 3A-inhibitors do not sensitize glioblastoma cell cultures against nitrosoureas. Clin Neuropathol 18: 1-8
24. Kolars JC, Lown KS, Schmiedlin-Ren P, Ghosh M, Fang C, Wrighton SA, Merion RM, Watkins PB (1994) CYP3A gene expression in human gut epithelium. Pharmacogenetics 4: 247-259
25. Kronbach T, Mathys D, Umeno M, Gonzalez FJ, Meyer UA (1989) Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. Mol Pharmacol 36: 89-96
26. LeDue BW, Sinclair PR, Shuster L, Sinclair JF, Evans JE, Greenblatt DJ (1993) Norcocaine and N-hydroxy-norcocaine formation in human liver microsomes: roles of cytochrome P-4503A4. Pharmacology 46: 294-300
27. Martínez C, Agúndez JAG, Gervasini G, Martín R, Bonítez J (1997) Tryptamine, a possible endogenous substrate for CYP2D6. Pharmacogenetics 7: 85-93
28. McFayden MCE, Melvin WT, Murray GI (1998) Regional distribution of individual forms of cytochrome P450 mRNA in normal adult human brain. Biochem Pharmacol 55: 825-830
29. Mills MH, Finlay DC, Haddad PR (1991) Determination of melatonin and monoamines in rat pineal using reversed-phase ion-interaction chromotography with fluorescence detection. J Chromatogr 564: 93-102
30. Mosseau DD (1993) Tryptamine: a metabolite of tryptophan implicated in various neurophyschiatric disorders. Metab Brain Dis 8: 1-44
31. Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Gotoh O, Okuda K, Nebert DW (1993) The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 12: 1-51
32. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW (1996) P450 superfamily: update on new sequences, gene mapping accession numbers and nomenclature. Pharmacogenetics 6: 1-42
33. Perez-Cruet J, Chase TN, Murphy DL (1974) Dietary regulation of brain tryptophan metabolism by plasma ratio of free tryptophan and neutral amino acids in humans. Nature 248: 693-695
34. Relling MV, Nemee J, Schuetz EG, Schuetz JD, Gonzalez FJ, Korzekwa KR (1994) O-Demethylation of epipodophyllotoxins in catalyzed by human cytochrome P450IIIA4. Mol Pharmacol 45: 352-358
35. Sedvall G, Fyro B, Gullberg B, Nyback H, Wiesel FA, Wode-Helgodt B (1980) Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity. Br J Psychiatry 136: 366-374
36. Segel IH (1975) Enzyme kinetics. Wiley, New York
37. Shimada T, Yamazaki H, Mimura M, Inui Y, Guenguerich FP (1994) Interindividual variations in human liver cytochromes P450 enzymes involved in the oxidations of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270: 414-423
38. Spina E, Avenoso A, Pollicino AM, Caputi AP, Fazio A, Pisani F (1992) Carbamazepine coadministration with fluoxetine and fluvoxamine. Ther Drug Monit 15: 247-250
39. von Moltke LL, Greenblatt DJ, Schmider J, Duan SX, Wright CE, Harmatz JS, Shader RI (1996) Midazolam hydroxylation by human liver microsomes in vitro: inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents. J Clin Pharmacol 36: 783-791
40. Wang H, Kawashima H, Strobel HW (1996) cDNA cloning of a novel CYP3A from rat brain. Biochem Biophys Res Commun 221: 157-162
41. Watkins PB (1994) Noninvasive test of CYP3A enzymes. Pharmacogenetics 4: 171-184
42. Wrighton SA, Ring BJ (1994) Inhibition of human CYP3A catalyzed 1′-hydroxy midazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine and nizatidine. Pharm Res 11: 921-924
43. Wrighton SA, Stevens JC (1992) The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol 22: 1-21
44. Yun CH, Okerholm RA, Guengerich FP (1993) Oxidation of the antihistaminic drug terfenadine in human liver microsomes: role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation. Drug Metab Dispos 21: 403-409
45. Zadik Z, Hamilton BP, Kowarski AA (1980) Integrated concentration of epinephrine and norepinephrine in normal subjects and in patients with mild essential hypertension. J Clin Endocrinol Metab 50: 842-845